1. Home
  2. ARDX vs GAM Comparison

ARDX vs GAM Comparison

Compare ARDX & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$7.99

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo General American Investors Inc.

GAM

General American Investors Inc.

HOLD

Current Price

$60.73

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
GAM
Founded
2007
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ARDX
GAM
Price
$7.99
$60.73
Analyst Decision
Strong Buy
Analyst Count
10
0
Target Price
$12.95
N/A
AVG Volume (30 Days)
6.3M
20.1K
Earning Date
02-19-2026
01-01-0001
Dividend Yield
N/A
5.74%
EPS Growth
N/A
N/A
EPS
N/A
11.67
Revenue
$398,234,000.00
N/A
Revenue This Year
$22.65
N/A
Revenue Next Year
$31.33
N/A
P/E Ratio
N/A
$3.95
Revenue Growth
58.12
N/A
52 Week Low
$3.21
$37.32
52 Week High
$8.17
$46.48

Technical Indicators

Market Signals
Indicator
ARDX
GAM
Relative Strength Index (RSI) 66.23 60.74
Support Level $6.73 $59.75
Resistance Level $7.25 $61.14
Average True Range (ATR) 0.57 0.90
MACD 0.14 0.09
Stochastic Oscillator 89.03 74.69

Price Performance

Historical Comparison
ARDX
GAM

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About GAM General American Investors Inc.

General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.

Share on Social Networks: